Make Smarter Decisions in Drug Design
We’re advancing small molecule drug discovery, with proprietary tools and technology, expertise, and an all-in approach to collaboration that sets you up for success. Tackling challenges, sharing insights, and driving progress together is how we aim to achieve success in every project.
Scale Up
Expand your capacity and capabilities
Services
Tailored services for your research objectives, including innovative software, CADD support, and access to experts.
Learn more
Software that works like a partner, delivering the confidence you need in hit discovery, hit-to lead, and lead optimization.
Ecosystem
A collaborative network with other service providers to deliver expanded capabilities that streamline and accelerate projects.
About Us
The go-to partner in small molecule drug design, with a team invested in your success.
Learn more
Case Studies
Let’s talk about how we can support your research!
What’s New
MFI Advances Compound to Round 2 in CACHE Challenge #6
MFI is advancing a compound to Round 2 in CACHE Challenge #6, which is focused on identifying novel inhibitors for SETDB1, an epigenetic target with a particularly challenging binding site.
Molecular Forecaster and TransBIOtech Partner to Accelerate the Discovery of New Small Molecule Therapeutics
Molecular Forecaster and TransBIOtech Partner to Accelerate the Discovery of New Small Molecule Therapeutics BOSTON, USA - MONTREAL AND LÉVIS, CANADA, JUNE 18, 2025 –Molecular Forecaster Inc. (MFI) and TransBIOTech are excited to announce a...
From Big Data to Big Brains: the Path to Smarter Drug Design in Canada
From Big Data to Big Brains: the Path to Smarter Drug Design in Canada EVERY DAY, WE HEAR about how artificial intelligence is ready to revolutionize Canadian life sciences. Claims that AI can or will make most things 'faster, cheaper, better' are...
A Select Few of Our Clients
A Select Few of Our Partners
What Our Clients and Partners Say